About this trial
The purpose of this study is to investigate if two medications; Rucaparib and Nivolumab used together or separately are better than the current best available treatment for patients who have had platinum-based chemotherapy for ovarian cancer.
Where’s this trial being run?Bon Secours Cork, Cork University Hospital, St James’s Hospital, University Hospital Limerick, and University Hospital Waterford
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Nivolumab and Rucaparib Combination Switch Maintenance following Front-Line Platinum-based Chemotherapy in Ovarian Cancer Patients)
|Principal Investigator:||Dr Dearbhaile Collins (Cork University Hospital)|
Clovis Oncology, Inc.
Global: May 2018
Ireland: February 2019
|Global Recruitment Target:||1012|
|Ireland Recruitment Target:||20 patients over 12 months|